# ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects

> **NCT03361540** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 56 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** ASP8302
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03361540
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361540, "ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03361540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*